ANAPTYSBIO, INC (ANAB) earnings date
Aug 10, 2026, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead. This date passed 100 days ago with no results filing on EDGAR yet.
- Fiscal period
- Q2 FY2026
- Confidence
- 26% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-12
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 40 days, typically, give or take 11 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Thu, Nov 12, 2026 | after close | 43 | 8-K |
| Q1 FY2026 | Tue, May 12, 2026 | after close | 42 | 8-K |
| Q4 FY2025 | Tue, Mar 3, 2026 | after close | 62 | 8-K |
| Q3 FY2025 | Tue, Nov 4, 2025 | after close | 35 | 8-K |
| Q2 FY2025 | Wed, Aug 6, 2025 | after close | 37 | 8-K |
| Q1 FY2025 | Mon, May 5, 2025 | after close | 35 | 8-K |
| Q4 FY2024 | Thu, Feb 27, 2025 | after close | 58 | 8-K |
| Q3 FY2024 | Tue, Nov 5, 2024 | after close | 36 | 8-K |
What they guided beta
| Q3 FY2026 | "Anaptys continues to expect to achieve >$390 million in annualized Jemperli royalties payable to Anaptys as early as 2029 at GSK’s peak monotherapy sales guidance of >$2.7 billion 2" exhibit |
| Q3 FY2026 | "Anaptys estimates Sagard will have accrued ~$330 million in royalties and sales milestones through September 30, 2026 and anticipates paydown of the remaining ~$270 million non-recourse debt monetization in calendar H2 2027" exhibit |
| Q3 FY2026 | "Regulatory submission expected in Japan in calendar H1 2027 and in Europe and China in calendar H2 2027" exhibit |
| Q3 FY2026 | "Regulatory decision expected in Europe in calendar H2 2027 o AZUR-2 – pivotal Phase 3 – dostarlimab versus standard of care in untreated TN40 or stage III dMMR/ MSI-H resectable colon cancer" exhibit |
| Q3 FY2026 | "Data expected in 2028 o AZUR-4 – Phase 2 – dostarlimab plus chemotherapy versus standard of care (chemotherapy) in untreated stage III MMRp/MSS resectable colon cancer" exhibit |
| Q1 FY2026 | "Anaptys continues to expect to achieve >$390 million in annualized Jemperli royalties payable to Anaptys as early as 2029 at GSK’s peak sales guidance of >$2.7 billion 2" exhibit |
| Q1 FY2026 | "Anaptys estimates Sagard will have accrued ~$275 million in royalties and sales milestones through Q1 2026 and anticipates paydown of the remaining ~$325 million non-recourse debt monetization by the end of Q2 2027 3" exhibit |
| Q1 FY2026 | "Data expected in H2 2026; U.S. FDA Breakthrough Therapy Designation" exhibit |
| Q1 FY2026 | "Data expected in 2028 o AZUR-4 – Phase 2 – dostarlimab plus chemotherapy versus standard of care (chemotherapy) in untreated stage III MMRp/MSS resectable colon cancer" exhibit |
| Q1 FY2026 | "Data expected in Q4 2026 o JADE – pivotal Phase 3 – dostarlimab monotherapy versus placebo in locally advanced unresected head and neck squamous cell carcinoma (PD-L1 CPS≥1) post chemoradiation" exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/ANAB
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/ANAB
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/ANAB/"><img src="https://veritasdata.dev/embed/ANAB.svg" alt="ANAB earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/ANAB/)
Script
<script async src="https://veritasdata.dev/embed/ANAB.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/ANAB"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.